References
- Kumar R, Priyadarshi RN, Anand U. Chronic renal dysfunction in cirrhosis: a new frontier in hepatology. World J Gastroenterol. 2021;27(11):1–4. doi: 10.3748/wjg.v27.i11.990.
- Tapper EB, Parikh ND. Diagnosis and management of cirrhosis and its complications a review. Jama-J Am Med Assoc. 2023;329(18):1589–1602. doi: 10.1001/jama.2023.5997.
- Nader MA, Aguilar R, Sharma P, et al. In-hospital mortality in cirrhotic patients with end-stage renal disease treated with hemodialysis versus peritoneal dialysis: a nationwide study. Perit Dial Int. 2017;37(4):464–471. doi: 10.3747/pdi.2016.00131.
- Dozio B, Scanziani R, Rovere G, et al. Hemoperitoneum in a continuous ambulatory peritoneal dialysis patient caused by a hepatocarcinoma treated with percutaneous embolization. Am J Kidney Dis. 2001;38(3):E11.
- Peng SJ, Yang CS. Hemoperitoneum in CAPD patients with hepatic tumors. Perit Dial Int. 1996;16(1):84–85. doi: 10.1177/089686089601600121.
- Lui SL, Yip PS, Lam MF, et al. Feasibility of reinstitution of CAPD after partial hepatectomy in patients with malignant hepatic tumors. Perit Dial Int. 2003;23(5):504–506. doi: 10.1177/089686080302300519.
- Posthuma N, van Eps RS, ter Wee PM. Hemoperitoneum due to (hepatocellular) adenoma. Perit Dial Int. 1998;18(4):446–447. doi: 10.1177/089686089801800421.
- Boyer A, Jegonday MA, Lanot A, et al. Percutaneous ablation for hepatocellular carcinoma and peritoneal dialysis. Perit Dial Int. 2017;37(6):656–658. +. doi: 10.3747/pdi.2017.00073.